Valuation (21%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -0.64 | 31.96 |
| PEG Ratio (TTM) | -0.12 | 10.97 |
| P/S Ratio (TTM) | 0.09 | 6.01 |
| P/B Ratio (TTM) | 1.09 | 4.83 |
| P/FCF Ratio (TTM) | -3.50 | 19.59 |
| Price to 5YR AVG Earnings Ratio | N/A | 30.28 |
| Price to 5YR AVG FCF Ratio | N/A | 42.37 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -115.48% | 6.19% |
| ROE (TTM) | -195.29% | 9.58% |
| Net Profit Margin (TTM) | -247.67% | -14.05% |
| ROIC 5YR AVG | N/A | 19.25% |
Growth (17%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -50.42% | -703.70% | N/A |
| Revenue | -11.84% | 169.35% | N/A |
| Net Income | -140.89% | -1,144.58% | N/A |
| Cash Flow | -82.60% | 16.74% | N/A |
Health (21%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.28 | 3.65 |
| Quick Ratio (TTM) | 0.27 | 3.13 |
| D/E Ratio (TTM) | 0.06 | 1.25 |
| Interest Coverage (TTM) | -78.24 | 1.34 |
| Piotroski F-Score | 3 | 6 |
| Altman Z-Score | N/A | 17.95 |
| LTL to 5YR AVG FCF | N/A | 1.14 |
| Shares Outstanding Growth 5YR AVG | N/A | -0.36% |